Amount Raised
$5.6 Million
Round Type
Post-IPO Equity
MiamiBiotechnologyPharmaceuticalBiopharmaInvestors
Description
On October 5, 2026, Telomir Pharmaceuticals, Inc. closed a private placement of 4,843,300 shares of common stock at $1.16 per share for gross proceeds of approximately $5.6 million. John Paul DeJoria, an existing significant shareholder, invested $1 million of the total.
Who else raised in Pharmaceutical and Biopharma around the same time
Companies in the same sectors as Telomir Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- ABVC BioPharma raised $3.4M (Convertible Note) on November 2, 2026.
- Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
- Disc raised $422M (Post-IPO Equity) on October 20, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
- Scinai Immunotherapeutics Ltd raised $4M (Post-IPO Equity) on October 14, 2026.
Who to call at Telomir Pharmaceuticals, and when
A new round usually means Telomir Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Telomir Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Telomir Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Telomir Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Telomir Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Telomir Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.